Filters
Results: 1 to 12 of 12
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Comprehensive Primary Immunodeficiency NGS Panel Fulgent Genetics United States | 1048 | 473 |
|
Comprehensive Cardiomyopathy NGS Panel Fulgent Genetics United States | 450 | 128 |
|
Noonan and RASopathies NGS Panel Fulgent Genetics United States | 235 | 26 |
|
Congenital Heart Defect NGS Panel Fulgent Genetics United States | 379 | 115 |
|
Fulgent Genetics United States | 178 | 1 |
|
Fulgent Genetics United States | 645 | 26 |
|
Full Comprehensive Cancer Panel Fulgent Genetics United States | 1166 | 141 |
|
PIK3CA-Related Overgrowth Spectrum Disorders with interpretation Clinical Genomics Laboratory Washington University in St. Louis United States | 6 | 1 |
|
Hypertrophic Cardiomyopathy NGS Panel Fulgent Genetics United States | 375 | 86 |
|
Somatic Overgrowth Panel with interpretation Clinical Genomics Laboratory Washington University in St. Louis United States | 86 | 49 |
|
Fulgent Genetics United States | 5130 | 4674 |
|
Comprehensive Cardiovascular NGS Panel Fulgent Genetics United States | 696 | 250 |
|
Results: 1 to 12 of 12
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.